153 related articles for article (PubMed ID: 15477789)
1. [Clinical value of degree of blood pressure lowering during use of effective doses of antianginal drugs].
Bochkareva EV; Kokurina EV; Voronina VP; Kucheriavaia NG; Butina EK
Kardiologiia; 2004; 44(10):43-8. PubMed ID: 15477789
[TBL] [Abstract][Full Text] [Related]
2. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the efficacy of a course of verapamil and nifedipine in patients with stable stenocardia by daily monitoring of the electrocardiogram].
Metelitsa VI; Vodop'ianova RS; Kokurina EV; Bochkareva EV; Urumbaev RK
Ter Arkh; 1989; 61(9):65-8. PubMed ID: 2595589
[TBL] [Abstract][Full Text] [Related]
5. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study.
Bassan MM; Weiler-Ravell D; Shalev O
Circulation; 1983 Sep; 68(3):568-75. PubMed ID: 6872169
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of patients with stable angina by combination of trinitrolong and propranolol].
Kukushkin SK; Metelitsa VI; Kokurina EV; Bochkarëva EV
Klin Med (Mosk); 1993; 71(5):30-3. PubMed ID: 8301980
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Zhiliaev EV; Urzhumova TV; Glazunov AV; Sorokoletov SM; Dzhanashiia PKh
Ter Arkh; 2000; 72(8):20-3. PubMed ID: 11019420
[TBL] [Abstract][Full Text] [Related]
9. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antianginal drug treatment by precordial exercise electrocardiography.
Cokkinos DV; Patsouros KD; Klotsotiras G; Kanellaki M; Patsilinakos J
Cardiology; 1981; 68 Suppl 2():141-6. PubMed ID: 6797732
[TBL] [Abstract][Full Text] [Related]
11. [Comparative effectiveness of finoptin, corinfar and their combination in patients with angina pectoris].
Sagirov AM; Romakov AIu; Sumarokov AB; Mazur NA
Kardiologiia; 1984 Nov; 24(11):91-6. PubMed ID: 6521214
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
13. The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect.
Bassan M; Weiler-Ravell D; Shalev O
Circulation; 1982 Oct; 66(4):710-6. PubMed ID: 7116588
[TBL] [Abstract][Full Text] [Related]
14. Verapamil or propranolol in the treatment of stable angina pectoris of effort.
Sigurd B; Hansen JF
Acta Med Scand Suppl; 1984; 681():75-81. PubMed ID: 6428170
[TBL] [Abstract][Full Text] [Related]
15. [Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris].
Voronkov LG; Lysenko AF
Kardiologiia; 1992; 32(11-12):67-70. PubMed ID: 1297887
[TBL] [Abstract][Full Text] [Related]
16. Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris.
Livesley B; Catley PF; Campbell RC; Oram S
Br Med J; 1973 Feb; 1(5850):375-8. PubMed ID: 4570671
[TBL] [Abstract][Full Text] [Related]
17. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
Foale RA; Vandenburg MJ
Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
[TBL] [Abstract][Full Text] [Related]
18. [Hyperbaric oxygenation and antianginal preparations: the effect of a single combined use on the functional indices of the state of the heart in patients with angina pectoris].
Seriakov VV; Efuni SN; Sidorenko BA
Anesteziol Reanimatol; 1992; (2):9-13. PubMed ID: 1416216
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris.
Packer M; Leon MB; Bonow RO; Kieval J; Rosing DR; Subramanian VB
Am J Cardiol; 1982 Oct; 50(4):903-12. PubMed ID: 6751066
[No Abstract] [Full Text] [Related]
20. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
Winsor T; Berger HJ
Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
